Scholars Central

Research articlePublished 4 Jul 2022

Major Depressive Disorder and Brain: A Neurotrophic Factor in Terms of Epigenetics and the Application of Natural Substances

Authors: Erhan Yarar

Journal of Antivirals & Antiretrovirals

Volume 14 · Issue 3 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Major Depressive Disorder (MDD) is the main source of incapacity in developed nations (350 million individuals are influenced around the world), with wrecking side effects including depressed state of brain, loss of interest or happiness, official dysfunctions, psychomotor impediment, suicide ideation, and eating and sleep unsettling influences. Natural substances and cognitive enhancers are drugs, supplements, nutraceuticals and utilitarian nourishments that are implied to improve mental capacities, for example, insight, memory, knowledge, inspiration, consideration and focus for all BDNF is a big player. Thus their neglected importance and their application in MDD and BDNF should be revisited. This review discusses multiple aspects of MDD and BDNF in terms of epigenetics and natural substances as treatment options and will comprise of exploratory research with the purpose to propose a framework based on the literature review and the research findings to readers.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Antivirals & Antiretrovirals.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Antivirals & Antiretrovirals
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Erhan Yarar”